Know Cancer

or
forgot password

A Clinical Study of X-Ray Volume Imaging to Evaluate the Daily Set-Up Accuracy of Conformal Prostate Radiotherapy


Phase 2
18 Years
N/A
Not Enrolling
Male
Prostatic Neoplasms

Thank you

Trial Information

A Clinical Study of X-Ray Volume Imaging to Evaluate the Daily Set-Up Accuracy of Conformal Prostate Radiotherapy


Inclusion Criteria:



- Diagnosis of adenocarcinoma of the prostate

- Patient undergoing escalated dose conformal external beam radiotherapy.

- Patient has low or intermediate risk prognostic factors: all of PSA <21, Gleason
score <8, clinical T category
- Informed consent

Exclusion Criteria:

- No diagnosis of adenocarcinoma of the prostate

- Patient not undergoing escalated dose conformal radiotherapy

- Patient does not have low or intermediate risk prognostic factors

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

To evaluate he feasibility of daily X-ray volume imaging during conformal radiotherapy.

Principal Investigator

Charles Catton, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Princess Margaret Hospital, Canada

Authority:

Canada: Ethics Review Committee

Study ID:

UHN REB 03-0483-CE

NCT ID:

NCT00188799

Start Date:

November 2003

Completion Date:

November 2004

Related Keywords:

  • Prostatic Neoplasms
  • Neoplasms
  • Prostatic Neoplasms

Name

Location